Functional absence of FADD in PLC/PRF/5 hepatoma cells: Possible involvement in the transformation to hepatoma in HBV-infected hepatocytes

Proceedings of the Society for Experimental Biology and Medicine

Volumn 221, Issue 1, 1999, Pages 72-79

  Suzuki, Atsushi ^a   Araki, Takashi ^b   Miura, Masayuki ^b   Tsutomi, Yumi ^a  

^a DAIICHI SANKYO CO   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL TRANSFORMATION; CELL VIABILITY; CHROMATIN CONDENSATION; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS INFECTION;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032931229     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-56.x     Document Type: Article

References (43)

1. Wyllie AH, Kerr JFR, Currie AR. Cell death. The significance apoptosis. Int Rev Cytol 68:251-306, 1980.
2. Nagata S, Golstein P. The Fas death factor. Science 267:1449-1456, 1995.
3. Suzuki A, Enari M, Eguchi Y, Matsuzawa A, Nagata S, Tsujimoto Y, Iguchi T. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J 15:211-215, 1996.
4. Suzuki A, Matsuzawa A, Iguchi T. Downregulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tracts. Oncogene 13:31-37, 1996.
5. Suzuki A, Enari M, Iguchi T. Effect of neonatal exposure to DES on Fas and Bcl-2 expression in the adult mouse vagina: An approach to the DES syndrome. Reprod Toxicol 10:465-470, 1996.
6. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809, 1993.
7. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3:409-413, 1997.
8. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184:2067-2072, 1996.
9. Suzuki A. The dominant role of CPP32 subfamily in Fas-mediated hepatitis. Proc Soc Exp Biol Med 217:450-454, 1998.
10. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:354-1359, 1994.
11. Berke G. The CTL's kiss of death. Cell 81:9-12, 1995.
12. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991.
13. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992.
14. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512, 1995.
15. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827, 1996.
16. Boldin MP, Goncharov TM, Golstev YV, Wallach D. Involvement of MACH, a novel MORT-1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85:803-815, 1996.
17. Gousevv AI, Engelhardt NV, Masseyeff R, Camain R, Basteris B. Immunofluorescent study of α-foetoprotein (α-fp) in liver and liver tumors. II. Localization of α-fp in the tissues of patients with primary liver cancer. Int J Cancer 7:207-217, 1971.
18. Hajnicka V, Fuchsberger N, Stancek D, Volna A, Cervenakova L. Synthesis of 23K acute-phase protein by HBV genome carrying PLC/PRF/5 human hepatoma cells. Acta Virol 36:581-584, 1992.
19. Tugizov SM, Savchenkova IP, Grabovskaya IL, Makarova NE, Eraizer TL, Revazova EP, Kushch AA. Changes in expression of surface and core antigens of hepatitis B virus in different mutant clones of hepatoma PLC-PRF-5 cells. Virus Res 30:189-203, 1993.
20. Fesus L. Biochemical events in naturally occurring forms of cell death. FEBS Lett 328:1-5, 1993.
21. Hasegawa J, Kamada S, Kamiike W, Shimizu S, Imazu T, Matsuda H, Tsujimoto Y. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res 56:1713-1718, 1996.
22. Suzuki A, Iwasaki M, Kato M, Wagai N. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp Cell Res 233:41-47, 1997.
23. Suzuki A, Iwasaki M, Wagai N. Involvement of cytoplasmic serine-proteinase and CPP32 subfamily in the molecular machinery of caspase 3 activation during Fas-mediated apoptosis. Exp Cell Res 233:48-55, 1997.
24. Yonehara S, Ishii A, Yonehara M. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989.
25. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Dongen JLV, Gilfillan MC, Shiels H, Hardwick JM, Thompson CB. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J 15:2685-2694, 1996.
26. Hill HD, Sraka J. Protein determination using bicinchoninic acid in the presence of sulfhydryl regents. Anal Biochem 170:203-208, 1988.
27. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 170:203-208, 1985.
28. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579-5588, 1995.
29. Tsujimoto Y, Yunis J, Nowell PC, Croce CM. Cloning of the chromosomal breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science 226:1097-1099, 1984.
30. Tsujimoto Y. Stress-resistance conferred by high level Bcl-2 α-protein in human B lymphoblastoid cell. Oncogene 4:1331-1336, 1989.
31. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993.
32. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619, 1993.
33. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736, 1996.
34. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell death proteases. Nature 388:300-304, 1997.
35. Sato T, Irie S, Ktada S, Reed JC. FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411-415, 1995.
36. Suzuki A, Goto Y, Iguchi T. Progression of PDMT is accompanied by lack of Fas and intense expression of Bcl-2 and PKC-ε. Carcinogenesis 18:883-887, 1997.
37. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69:597-604, 1992.
38. Xue D, Horvitz HR. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377:248-251, 1995.
39. Tewari M, Dixit VM. Fas- and TNF-induced apoptosis is inhibited by the Poxvirus crmA gene product. J Biol Chem 270:3255-3260, 1995.
40. Enari M, Hug H, Nagata S. Involvement of an ICE-like proteinase in Fas- mediated apoptosis. Nature 375:78-81, 1995.
41. Irmler M, Thome M, Hahne M, Schneider P, Hofman K, Steiner V, Bodmer J-L, Schroter M, Burns K, Mattman C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997.
42. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas- mediated apoptosis: Activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17:931-940, 1998.
43. Thornbery NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstorm PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW. A combinatorial approach defined specificities of members of the caspase family and granzyme B: Functional relationships established for key mediators of apoptosis. J Biol Chem 272:17907-17911, 1997.